GGrantIndex
← Search

VALIDATION AND CHARACTERIZATION OF A NOVEL PROSTATE CANCER-SPECIFIC GENOMIC DELETION ASSOCIATED WITH TMPRSS2-ERG TRANSLOCATION

$114,098FY2011Department of the ArmyDOD

Sloan-Kettering Institute For Cancer Research

Investigators

View source on USAspending →
VALIDATION AND CHARACTERIZATION OF A NOVEL PROSTATE CANCER-SPECIFIC GENOMIC DELETION ASSOCIATED WITH TMPRSS2-ERG TRANSLOCATION · GrantIndex